183 related articles for article (PubMed ID: 26433667)
21. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update.
Berek JS; Renz M; Kehoe S; Kumar L; Friedlander M
Int J Gynaecol Obstet; 2021 Oct; 155 Suppl 1(Suppl 1):61-85. PubMed ID: 34669199
[TBL] [Abstract][Full Text] [Related]
22. Fallopian tube cancer: stepchild or mother?
Gershenson DM
Gynecol Oncol; 2007 Dec; 107(3):386-7. PubMed ID: 18053873
[No Abstract] [Full Text] [Related]
23. Trends in ovarian, fallopian tube, and primary peritoneal cancer incidence, mortality, and survival: A 15-year population-based analysis.
Somasegar S; Reddy RA; Chow S; Dorigo O; Renz M; Karam A
Gynecol Oncol; 2024 May; 184():190-197. PubMed ID: 38330833
[TBL] [Abstract][Full Text] [Related]
24. Serous ovarian, fallopian tube and primary peritoneal cancers: a common disease or separate entities - a systematic review.
Sørensen RD; Schnack TH; Karlsen MA; Høgdall CK
Gynecol Oncol; 2015 Mar; 136(3):571-81. PubMed ID: 25615934
[TBL] [Abstract][Full Text] [Related]
25. Patterns of First Recurrence in African American Patients with High Grade Epithelial Ovarian Carcinoma.
Singh S; Armstrong A; Pettigrew G; Resnick K
Gynecol Obstet Invest; 2016; 81(3):215-9. PubMed ID: 26485364
[TBL] [Abstract][Full Text] [Related]
26. Prognostic role of early versus late onset of bone metastasis in patients with carcinoma of the ovary, peritoneum and fallopian tube.
Sehouli J; Olschewski J; Schotters V; Fotopoulou C; Pietzner K
Ann Oncol; 2013 Dec; 24(12):3024-8. PubMed ID: 24130264
[TBL] [Abstract][Full Text] [Related]
27. Wilms tumor gene immunoreactivity in primary serous carcinomas of the fallopian tube, ovary, endometrium, and peritoneum.
Hashi A; Yuminamochi T; Murata S; Iwamoto H; Honda T; Hoshi K
Int J Gynecol Pathol; 2003 Oct; 22(4):374-7. PubMed ID: 14501819
[TBL] [Abstract][Full Text] [Related]
28. Key features of extrauterine pelvic serous tumours (fallopian tube, ovary, and peritoneum).
Delair D; Soslow RA
Histopathology; 2012 Sep; 61(3):329-39. PubMed ID: 22372521
[TBL] [Abstract][Full Text] [Related]
29. Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum.
Prat J;
Cancer; 2015 Oct; 121(19):3452-4. PubMed ID: 26110780
[TBL] [Abstract][Full Text] [Related]
30. Staging classification for cancer of the ovary and the fallopian tube should include in situ carcinoma.
Tjalma WA
Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():207. PubMed ID: 26589439
[No Abstract] [Full Text] [Related]
31. Assignment of primary site in high-grade serous tubal, ovarian and peritoneal carcinoma: a proposal.
Singh N; Gilks CB; Wilkinson N; McCluggage WG
Histopathology; 2014 Aug; 65(2):149-54. PubMed ID: 24660659
[TBL] [Abstract][Full Text] [Related]
32. Laparoscopic staging in patients with incompletely staged cancers of the uterus, ovary, fallopian tube, and primary peritoneum: a Gynecologic Oncology Group (GOG) study.
Spirtos NM; Eisekop SM; Boike G; Schlaerth JB; Cappellari JO
Am J Obstet Gynecol; 2005 Nov; 193(5):1645-9. PubMed ID: 16260204
[TBL] [Abstract][Full Text] [Related]
33. Unexpected gastrointestinal toxicity from Docetaxel/Carboplatin/Erlotinib followed by maintenance Erlotinib treatment for newly diagnosed stage III/IV ovarian cancer, primary peritoneal, or fallopian tube cancer.
Holmberg LA; Goff B; Veljovich D
Gynecol Oncol; 2011 May; 121(2):426. PubMed ID: 21324515
[No Abstract] [Full Text] [Related]
34. [New FIGO classification of ovarian, fallopian tube and primary peritoneal cancer].
Höhn AK; Einenkel J; Wittekind C; Horn LC
Pathologe; 2014 Jul; 35(4):322-6. PubMed ID: 24899496
[TBL] [Abstract][Full Text] [Related]
35. Demographic clinical and prognostic characteristics of primary ovarian, peritoneal and tubal adenocarcinomas of serous histology--a prospective comparative study.
Schnack TH; Sørensen RD; Nedergaard L; Høgdall C
Gynecol Oncol; 2014 Nov; 135(2):278-84. PubMed ID: 25168689
[TBL] [Abstract][Full Text] [Related]
36. Is comprehensive surgical staging needed for thorough evaluation of early-stage ovarian carcinoma?
Garcia-Soto AE; Boren T; Wingo SN; Heffernen T; Miller DS
Am J Obstet Gynecol; 2012 Mar; 206(3):242.e1-5. PubMed ID: 22055337
[TBL] [Abstract][Full Text] [Related]
37. [Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma].
Liang Y; Chen XD; Lü BJ; Zhou CY; Zhang XF; Shi HY
Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):724-8. PubMed ID: 22321343
[TBL] [Abstract][Full Text] [Related]
38. [The Fallopian tube odyssey: from the ovary to the tube. About high-grade serous ovarian carcinoma].
Chêne G; Dauplat J; Radosevic-Robin N; Cayre A; Penault-Llorca F
Bull Cancer; 2013; 100(7-8):757-64. PubMed ID: 23831931
[TBL] [Abstract][Full Text] [Related]
39. Phase III trial of upfront debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0602.
Onda T; Matsumoto K; Shibata T; Sato A; Fukuda H; Konishi I; Kamura T; Yoshikawa H;
Jpn J Clin Oncol; 2008 Jan; 38(1):74-7. PubMed ID: 18258715
[TBL] [Abstract][Full Text] [Related]
40. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
